Availabe from: 3
Others have shown that CGM appears to be safe and comparable to fingerstick monitoring in type 2 diabetes pregnancy [51, 53,54,55], but have lacked statistical power to examine effectiveness on pregnancy outcomes [53, 56, 57]
Niosomes from 80s to present: the state of the art
While teplizumab does not treat or prevent Type 1 diabetes, it delays its onset by an average of two years
Without an insulin comparison, a selective inhibitor or a null background, an effect measured after adding this protein cannot be assigned cleanly to IGF-1R as opposed to the insulin receptor or to hybrid receptors
When applied with common sense, DEET-based repellents can be expected to provide a safe as well as a long-lasting repellent effect